Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa
-
Published:2019-07-04
Issue:1
Volume:4
Page:45-60
-
ISSN:2509-4262
-
Container-title:PharmacoEconomics - Open
-
language:en
-
Short-container-title:PharmacoEconomics Open
Author:
Boyer S., Nishimwe M. L.ORCID, Sagaon-Teyssier L., March L., Koulla-Shiro S., Bousmah M.-Q., Toby R., Mpoudi-Etame M. P., Ngom Gueye N. F., Sawadogo A., Kouanfack C., Ciaffi L., Spire B., Delaporte E., Delaporte E., Koulla-Shiro S., Ndour C. T., Sawadogo A., Le Moing V., Reynes J., Calmy A., Ciaffi L., Girard P. M., Eholie S., Chaix M. L., Kouanfack C., Tita I., Bazin B., Garcia P., Guiard-Schmid J. B., Izard S., Eymard-Duvernay S., Peeters M., Serrano L., Cournil A., Diallo I., Mben J. M., Toby R., Manga N., Ayangma L., Taman B., Kabore F. N., Kamboule E., Zoungrana J., Diouf A., Diallo M., Fortes L., Ngom Gueye N. F., Batista G., Aghokeng A., Guichet E., Abessolo H., Essomba C., Manirakiza G., Essomba F., Mbarga T., Epanda S., Bikie A., Nke T., Massaha N., Nke E., Ngolle M., Bikobo D., Abologo L., Elat O., Laborde-Balen G., Diop A., Diouf B., Bara N., Koita Fall M. B., Toure Kane C., Seck F. B., Ba S., Njantou P., Ndyaye A., Hema A., Fao P., Ouedrago P., Traore R., Sanou Y., Bado G., Coulibaly M., Some E., Some J., Kambou A., Tapsoba A., Sombie D., Sanou S., Traore B., Flandre P., Michon C., Drabo J., Simon F.,
Funder
Agence Nationale de Recherche sur le Sida et les Hépatites Virales European and Developing Countries Clinical Trials Partnership
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference41 articles.
1. World Health Organization. WHO HIV update: global epidemic, progress in scale up and policy uptake [Internet]; 2018. http://www.who.int/hiv/data/2017_global_summary_web_v11.pptx?ua=1. Accessed 23 Oct 2018. 2. World Health Organization, Habiyambere V. WHO global ARVs and diagnostic use survey in 2015 in low and middle-income countries [Internet]; 2016. http://www.who.int/hiv/amds/amds2016-ppt-WHO-2015ARVUseSurvey.pdf. Accessed 23 Oct 2018. 3. Onoya D, Nattey C, Budgell E, van den Berg L, Maskew M, Evans D, et al. Predicting the need for third-line antiretroviral therapy by identifying patients at high risk for failing second-line antiretroviral therapy in South Africa. AIDS Patient Care STDs. 2017;31:205–12. 4. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach [Internet]; 2016. http://www.deslibris.ca/ID/10089566. Accessed 11 Sept 2018. 5. World Health Organization, Haile-Selassie H, World Health Organization, Department of HIV/AIDS, Centers for Disease Control and Prevention (U.S.), Global Fund to Fight AIDS T and Malaria, et al. WHO HIV drug resistance report 2017 [Internet]; 2017. http://apps.who.int/iris/bitstream/10665/255896/1/9789241512831-eng.pdf. Accessed 11 Sept 2018.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|